Covidien Ltd. (COV-N) Stock Predictions - Stockchase
WATCH LIST
25
Covidien Ltd. (COV-N)

ON STOCKCHASE SINCE Sep 2008

Acquired by Medtronic (January 2015)

biotechnology/pharmaceutical

Covidien Ltd.

COV-N

4 watching          
Join the Discussion

Covidien Ltd. (COV-N) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about COV-N



  • All
  • Filtered
Signal Opinion Expert
SELL
Covidien Ltd.(COV-N) 

November 3, 2014

Company being taken over (by MDT-N) for a tax inversion and he sold it because the legislative agenda might change and tax inversion may not continue to be allowed.  He would go back after the deal closes.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Company being taken over (by MDT-N) for a tax inversion and he sold it because the legislative agenda might change and tax inversion may not continue to be allowed.  He would go back after the deal closes.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$92.420
Owned Owned
Unknown

SELL
Covidien Ltd.(COV-N) 

September 5, 2014

Medical devices.  He sold it when they were acquired.  Was a great performer.  He is worried US government may ban these tax inversion strategies.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Medical devices.  He sold it when they were acquired.  Was a great performer.  He is worried US government may ban these tax inversion strategies.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$88.440
Owned Owned
No

BUY
Covidien Ltd.(COV-N) 

June 23, 2014

He is going to tender it to the Medtronic (MDT-N) offer.  He likes the combined company and it will be a core holding for him.  Likes the healthcare business and where they are in it.  The combined company will have more clout in dealing with vendors and customers.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

He is going to tender it to the Medtronic (MDT-N) offer.  He likes the combined company and it will be a core holding for him.  Likes the healthcare business and where they are in it.  The combined company will have more clout in dealing with vendors and customers.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$90.950
Owned Owned
Yes

BUY
Covidien Ltd.(COV-N) 

March 21, 2014

(Market Call Minute.) US healthcare stock. He likes the area and he likes the company. Buy it and hold.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Market Call Minute.) US healthcare stock. He likes the area and he likes the company. Buy it and hold.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$70.440
Owned Owned
Yes

BUY
Covidien Ltd.(COV-N) 

January 30, 2014

Markets have run up so substantially last year that there are pockets of value but not a lot generally everywhere. He is hoping that Q1 provides some opportunities for him to enter into names that he wants to buy. If  looking for companies that have stable like characteristics and generally grow slowly over time, these are the kinds of companies you want to own. He is adding this for new clients.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Markets have run up so substantially last year that there are pockets of value but not a lot generally everywhere. He is hoping that Q1 provides some opportunities for him to enter into names that he wants to buy. If  looking for companies that have stable like characteristics and generally grow slowly over time, these are the kinds of companies you want to own. He is adding this for new clients.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Darren Sissons

Vice Presi, Campbell Lee & Ross...

Price Price
$68.560
Owned Owned
Yes

PAST TOP PICK
Covidien Ltd.(COV-N) 

December 30, 2013

(Top Pick Dec 18/12, Up 30.11%) Economically sensitive because more employment means more health plans and more elective surgeries.  Spun out a drug division and that helped his returns.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Top Pick Dec 18/12, Up 30.11%) Economically sensitive because more employment means more health plans and more elective surgeries.  Spun out a drug division and that helped his returns.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$67.910
Owned Owned
Yes

BUY
Covidien Ltd.(COV-N) 

November 25, 2013

Buying for new clients.  It is the largest hospital supply company.  Operating room supplies, disposable.  Economically sensitive.  Operating rooms are used more when people can do elective surgeries – employed and with health insurance.  1.9% dividend.  They want to increase their payout.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Buying for new clients.  It is the largest hospital supply company.  Operating room supplies, disposable.  Economically sensitive.  Operating rooms are used more when people can do elective surgeries – employed and with health insurance.  1.9% dividend.  They want to increase their payout.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$67.050
Owned Owned
Unknown

BUY
Covidien Ltd.(COV-N) 

October 16, 2013

American company headquartered in Ireland for tax reasons.  Hospital supply, surgical supplies.  Goes up and down with the economy because with insurance when you are working you get more elective surgery.  Bought when people were out of work and stock price was depressed.  It was not a problem with the company but with the economy.  Leader in its sector.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

American company headquartered in Ireland for tax reasons.  Hospital supply, surgical supplies.  Goes up and down with the economy because with insurance when you are working you get more elective surgery.  Bought when people were out of work and stock price was depressed.  It was not a problem with the company but with the economy.  Leader in its sector.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$62.400
Owned Owned
Yes

PAST TOP PICK
Covidien Ltd.(COV-N) 

July 31, 2013

(A Top Pick July 27/12. Up 24.42%.) One of the things he liked is that it was US-based but Irish Incorporated for tax purposes. In the hospital supply business. Had a generic drug subsidiary, which was spun out to the shareholders at the end of June, which he sold as soon as he got it.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(A Top Pick July 27/12. Up 24.42%.) One of the things he liked is that it was US-based but Irish Incorporated for tax purposes. In the hospital supply business. Had a generic drug subsidiary, which was spun out to the shareholders at the end of June, which he sold as soon as he got it.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$61.630
Owned Owned
Yes

PAST TOP PICK
Covidien Ltd.(COV-N) 

July 25, 2013

(A Top Pick July 13/12. 29.1%.) Domiciled in Ireland but listed in the US for tax reasons. They make things like surgical gowns, scalpels and the kinds of things that hospitals cannot do without.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(A Top Pick July 13/12. 29.1%.) Domiciled in Ireland but listed in the US for tax reasons. They make things like surgical gowns, scalpels and the kinds of things that hospitals cannot do without.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Darren Sissons

Vice Presi, Campbell Lee & Ross...

Price Price
$61.020
Owned Owned
Yes

PAST TOP PICK
Covidien Ltd.(COV-N) 

June 18, 2013

(A Top Pick June 26/12. Up 28.13%.)

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(A Top Pick June 26/12. Up 28.13%.)

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$65.940
Owned Owned
Unknown

PAST TOP PICK
Covidien Ltd.(COV-N) 

May 17, 2013

Recommended at $52.35 now $65.86, up 27.95%  An American company based in Ireland for tax reasons. Creates health care products, used in surgery or doctors offices. They sensitive to the economy because when people aren't working they tend to put off surgeries. They are splitting off their generic drug division, which he views as a very positive move.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

Recommended at $52.35 now $65.86, up 27.95%  An American company based in Ireland for tax reasons. Creates health care products, used in surgery or doctors offices. They sensitive to the economy because when people aren't working they tend to put off surgeries. They are splitting off their generic drug division, which he views as a very positive move.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$65.770
Owned Owned
Unknown

TOP PICK
Covidien Ltd.(COV-N) 

December 18, 2012

(A Top Pick Dec 14/11. Up 40.38%.) Provides small medical devices and services in the ORs, so it is economically sensitive. Headquartered in Ireland for tax purposes so the stock has lagged because many view it as European company. Also, have a generic drug division and will be spinning this off near the end of the 1st half of 2013.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(A Top Pick Dec 14/11. Up 40.38%.) Provides small medical devices and services in the ORs, so it is economically sensitive. Headquartered in Ireland for tax purposes so the stock has lagged because many view it as European company. Also, have a generic drug division and will be spinning this off near the end of the 1st half of 2013.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$58.110
Owned Owned
Yes

PAST TOP PICK
Covidien Ltd.(COV-N) 

November 2, 2012

(A Top Pick Oct 24/11. Up 21.17%.) Hospital supply company, mostly small things that go into the operating room. Also, have a generic drug division that they are in the process of spinning out. Based in Ireland for tax reasons and is really run out of Boston.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(A Top Pick Oct 24/11. Up 21.17%.) Hospital supply company, mostly small things that go into the operating room. Also, have a generic drug division that they are in the process of spinning out. Based in Ireland for tax reasons and is really run out of Boston.

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$55.450
Owned Owned
Yes

TOP PICK
Covidien Ltd.(COV-N) 

July 27, 2012

Cash cow. Likes health care a lot. They are in 3 different businesses. 1) Low-priced medical devices, 2) medical supplies that are used in operating rooms and 3) generic pharmaceuticals, which they will be spinning out in the next 12 months to their shareholders. They announced their intention to return 50% of their free cash flow to the shareholders. 1.3% dividend.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Cash cow. Likes health care a lot. They are in 3 different businesses. 1) Low-priced medical devices, 2) medical supplies that are used in operating rooms and 3) generic pharmaceuticals, which they will be spinning out in the next 12 months to their shareholders. They announced their intention to return 50% of their free cash flow to the shareholders. 1.3% dividend.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$55.530
Owned Owned
Yes

Showing 1 to 15 of 25 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days